Fisher Michal
SEC Form 4 insider trading activity
Fisher Michal has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Fisher Michal is listed as Director at CNS Pharmaceuticals, Inc. Inside the rolling window, Fisher Michal reported 1 open-market purchase totaling $10K in CNSP and no open-market sales.
Companies traded
Other insiders at CNSP
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fisher Michal made?
Fisher Michal has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Fisher Michal trade?
Fisher Michal has filed SEC Form 4 disclosures for 1 company, including CNSP.
When was Fisher Michal's most recent SEC Form 4 filing?
Fisher Michal's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Fisher Michal's total buy and sell value in the current window?
Inside the rolling retention window, Fisher Michal bought $10K and sold $0 based on SEC Form 4 filings.
What was Fisher Michal's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,000 CNSP shares on 2026-05-18, worth $10K, per SEC Form 4 filings.